Robert Glanzman's Insider Trades & SAST Disclosures

Robert Glanzman's most recent trade in Clene Inc was a trade of 4,717 Common Stock done at an average price of $2.0 . Disclosure was reported to the exchange on May 16, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Clene Inc
Robert Glanzman Chief Medical Officer Sale of securities on an exchange or to another person at price $ 2.03 per share. 16 May 2022 4,717 10,564 - 2.0 9,576 Common Stock
Clene Inc
Robert Glanzman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 140,000 140,000 - - Stock Options (Right to buy)
Clene Inc
Robert Glanzman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Nov 2021 100,000 100,000 - - Stock Options (Right to buy)
Clene Inc
Robert Glanzman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 15,281 15,281 - 0 Common Stock
Clene Inc
Robert Glanzman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Apr 2021 95,000 95,000 - - Stock Options (Right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades